The Characteristics of Patients Who Develop Long-COVID Symptoms
Researchers sought to examine the demographic and clinical characteristics of patients who developed long COVID.
COVID19
Loss of Smell, Taste Less Likely With Newer COVID-19 Variants
A lower risk for developing chemosensory loss was observed with alpha, delta, and omicron variants.
FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
One in Nine Discharged After COVID-19 Admission Die or Are Readmitted
One in 9 patients hospitalized for COVID-19 died or were readmitted to the hospital within 30 days of their initial discharge.
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
A third shot can be given at least five months after healthy children complete the two-dose vaccine series.
Prostate, Bladder Cancer Care Delays Common During Pandemic
Study characterized patient-reported delays in care of prostate cancer and bladder cancer at the national level.
Health Improves Over Two Years for COVID-19 Hospitalization Survivors
Improvements were seen in physical and mental health, but survivors still had more symptoms than controls at two years.
Cognitive Impairment 3 to 12 Months After COVID-19 Hospitalization
Researchers assessed the frequency and severity of cognitive impairments over time and specifically 1 year after hospitalization in patients who contracted COVID-19.
Younger Cancer Patients May Be at High Risk of Death From COVID-19
Younger patients with cancer are “a high-risk population for poor outcomes from COVID-19,” according to researchers.
Persistent Viral Shedding Common in Hospitalized COVID-19 Patients
Persistent viral shedding was associated with an increased risk of in-hospital delirium and death at 6 months.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...